Cargando…
Crosslinking-Induced Corneal Endothelium Dysfunction and Its Protection by Topical Ripasudil Treatment
PURPOSE: To investigate the changes of corneal endothelium under different crosslinking conditions and the protective effect of ripasudil. METHODS: Corneal crosslinking groups were infiltrated with riboflavin and subsequently irradiated with 0.54 J/cm(2) or 1.08 J/cm(2) UVA, while noncrosslinking gr...
Autores principales: | Wang, Xuemei, Zhong, Yanlin, Liang, Minghui, Lin, Zhirong, Wu, Huping, Li, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776458/ https://www.ncbi.nlm.nih.gov/pubmed/35069933 http://dx.doi.org/10.1155/2022/5179247 |
Ejemplares similares
-
Topical Ripasudil for the Treatment of Primary Corneal Endothelial Degeneration in Dogs
por: Michalak, Sarah R., et al.
Publicado: (2022) -
Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival
por: Inomata, Takenori, et al.
Publicado: (2020) -
Safety and efficacy of repeated crosslinking assisted by transepithelial double-cycle iontophoresis in keratoconus progression after primary corneal crosslinking
por: Wu, Huping, et al.
Publicado: (2021) -
Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
por: Tanihara, Hidenobu, et al.
Publicado: (2023) -
The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery
por: Fujimoto, Hisataka, et al.
Publicado: (2021)